Molecular Oncology

Papers
(The H4-Index of Molecular Oncology is 29. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-11-01 to 2025-11-01.)
ArticleCitations
Issue Information124
114
Issue Information108
91
Issue Information78
Transcriptome‐wide analysis of circRNA and RBP profiles and their molecular relevance for GBM75
Corrigendum to: Small proline‐rich repeat protein 3 enhances the sensitivity of esophageal cancer cells in response to DNA damage‐induced apoptosis70
Microglia limit brain tumor development by restricting tumor cell proliferation and inducing T‐cell immunity67
Vandetanib drives growth arrest and promotes sensitivity to imatinib in chronic myeloid leukemia by targeting ephrin type‐B receptor 466
Targeted therapy of advanced parathyroid carcinoma guided by genomic and transcriptomic profiling62
Development of an optimized, non‐stem cell line for intranasal delivery of therapeutic cargo to the central nervous system60
Gene signature predicting recurrence in oral squamous cell carcinoma is characterized by increased oxidative phosphorylation50
PoDCall: a robust tool for automated droplet classification in DNA‐methylation droplet digital PCR48
47
Correction to “SPT6 recruits SND1 to co‐activate human telomerase reverse transcriptase to promote colon cancer progression”46
The multispecies microbial cluster of Fusobacterium, Parvimonas, Bacteroides and Faecalibacterium as a precision biomarker for colorectal cancer diagnosis45
Precision Cancer Medicine 2.0—Oncology in the postgenomic era41
Unraveling LINE‐1 retrotransposition in head and neck squamous cell carcinoma40
The selenoenzyme type I iodothyronine deiodinase: a new tumor suppressor in ovarian cancer37
Peripheral blood leukocyte signatures as biomarkers in relapsed ovarian cancer patients receiving combined anti‐CD73/anti‐PD‐L1 immunotherapy in arm A of the NSGO36
Interaction between membranous EBP50 and myosin 9 as a favorable prognostic factor in ovarian clear cell carcinoma35
Cancer‐associated fibroblasts educate normal fibroblasts to facilitate cancer cell spreading and T‐cell suppression34
Proteomics on malignant pleural effusions reveals ERα loss in metastatic breast cancer associates with SGK1–NDRG1 deregulation34
TGFβ selects for pro‐stemness over pro‐invasive phenotypes during cancer cell epithelial–mesenchymal transition34
Whole‐genome sequencing of cell‐free DNA reveals DNA of tumor origin in plasma from patients with colorectal adenomas33
Prognostic and predictive impact of gene expression in node‐positive early breast cancer patients receiving dose‐dense versus standard‐dose adjuvant chemotherapy30
NKG2A and circulating extracellular vesicles are key regulators of natural killer cell activity in prostate cancer after prostatectomy30
Correction to “Mutant p53 proteins counteract autophagic mechanism sensitizing cancer cells to mTOR inhibition”30
Molecular and functional profiling unravels targetable vulnerabilities in colorectal cancer29
Unraveling the metastasis‐preventing effect of miR‐200c in vitro and in vivo29
An arms‐race against resistance: leukemic stem cells and lineage plasticity29
0.19148707389832